Pharmhouse Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +86.3% | -3.2% | -11.7% | – | |
| – | – | – | – | – | – | – | – | – | +100.9% | +0.7% | -8.3% | – | |
| – | – | – | – | – | – | – | – | – | +82.4% | -4.4% | -12.7% | – | |
| – | +10,808.4% | -24.9% | -90.1% | +519.8% | -89.2% | +912.3% | +459.1% | +148.7% | +625.9% | -59.3% | -35.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,129.3% | -76.9% | +729.5% | -72.1% | +298.3% | -57.7% | +2,420.2% | -95.4% | -63.9% | -89.7% | +8,305.3% | – | |
| – | -153.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -153.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -135.2% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.